133 related articles for article (PubMed ID: 16301242)
1. Identification of the central imidazoline receptor subtype involved in modulation of halothane-epinephrine arrhythmias in rats.
Kagawa K; Hayashi Y; Itoh I; Iwasaki M; Takada K; Kamibayashi T; Yamatodani A; Mashimo T
Anesth Analg; 2005 Dec; 101(6):1689-1694. PubMed ID: 16301242
[TBL] [Abstract][Full Text] [Related]
2. Role of imidazoline-preferring receptors in the genesis of epinephrine-induced arrhythmias in halothane-anesthetized dogs.
Hayashi Y; Kamibayashi T; Maze M; Yamatodani A; Sumikawa K; Kuro M; Yoshiya I
Anesthesiology; 1993 Mar; 78(3):524-30. PubMed ID: 7681269
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
Bock C; Niederhoffer N; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs.
Mest HJ; Thomsen P; Raap A
Ann N Y Acad Sci; 1995 Jul; 763():620-33. PubMed ID: 7677382
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic action of rilmenidine on adrenaline-induced arrhythmia via central imidazoline receptors in halothane-anaesthetized dogs.
Mammoto T; Kamibayashi T; Hayashi Y; Yamatodani A; Takada K; Yoshiya I
Br J Pharmacol; 1996 Apr; 117(8):1744-8. PubMed ID: 8732285
[TBL] [Abstract][Full Text] [Related]
6. Further characterization of the receptor mechanism involved in the antidysrhythmic effect of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs.
Kamibayashi T; Mammoto T; Hayashi Y; Yamatodani A; Takada K; Sasaki S; Yoshiya I
Anesthesiology; 1995 Nov; 83(5):1082-9. PubMed ID: 7486159
[TBL] [Abstract][Full Text] [Related]
7. Effects of imidazoline receptor ligands on monoamine synthesis in the rat brain in vivo.
Sastre-Coll A; Esteban S; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jul; 360(1):50-62. PubMed ID: 10463334
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of I(1)-antihypertensive agent moxonidine against neurogenic cardiac arrhythmias in halothane-anesthetized rabbits.
Poisson D; Christen MO; Sannajust F
J Pharmacol Exp Ther; 2000 Jun; 293(3):929-38. PubMed ID: 10869394
[TBL] [Abstract][Full Text] [Related]
9. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.
Haxhiu MA; Dreshaj I; Schäfer SG; Ernsberger P
J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S1-8. PubMed ID: 7533221
[TBL] [Abstract][Full Text] [Related]
10. Activation of phosphatidylinositol 3-kinase/Akt signaling pathway and endogenous nitric oxide are needed for the antiarrhythmic effect of centrally administered rilmenidine.
Yamanaka H; Hayashi Y; Iwasaki M; Kamibayashi T; Yamatodani A; Mashimo T
Eur J Pharmacol; 2010 Nov; 647(1-3):155-60. PubMed ID: 20816810
[TBL] [Abstract][Full Text] [Related]
11. Rilmenidine prevents epinephrine-induced arrhythmias in halothane-anesthetized dogs.
Mammoto T; Kamibayashi T; Hayashi Y; Takada K; Yamatodani A; Yoshiya I
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S40-3. PubMed ID: 8642804
[TBL] [Abstract][Full Text] [Related]
12. Circulatory effect of TCS-80, a new imidazoline compound, in rats.
Boblewski K; Lehmann A; Sączewski F; Sączewski J; Kornicka A; Marchwińska A; Rybczyńska A
Pharmacol Rep; 2016 Aug; 68(4):715-9. PubMed ID: 27127910
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy.
Cao C; Kang CW; Kim SZ; Kim SH
Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H150-6. PubMed ID: 14975931
[TBL] [Abstract][Full Text] [Related]
14. The effect of imidazoline receptors and alpha2-adrenoceptors on the anesthetic requirement (MAC) for halothane in rats.
Kagawa K; Mammoto T; Hayashi Y; Kamibayashi T; Mashimo T; Yoshiya I
Anesthesiology; 1997 Oct; 87(4):963-7. PubMed ID: 9357900
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the involvement of central I1 imidazoline receptor in ethanol counteraction of clonidine hypotension in spontaneously hypertensive rats.
El-Mas MM; Abdel-Rahman AA
J Cardiovasc Pharmacol; 2001 Sep; 38(3):417-26. PubMed ID: 11486246
[TBL] [Abstract][Full Text] [Related]
16. Presynaptic effects of moxonidine in isolated buffer perfused rat hearts: role of imidazoline-1 receptors and alpha2-adrenoceptors.
Schäfer U; Burgdorf C; Engelhardt A; Kurz T; Richardt G
J Pharmacol Exp Ther; 2002 Dec; 303(3):1163-70. PubMed ID: 12438540
[TBL] [Abstract][Full Text] [Related]
17. The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.
Ernsberger P; Friedman JE; Koletsky RJ
J Hypertens Suppl; 1997 Jan; 15(1):S9-23. PubMed ID: 9050981
[TBL] [Abstract][Full Text] [Related]
18. I1-imidazoline receptors and cholinergic outflow to the airways.
Haxhiu MA; Dreshaj IA; McFadden CB; Erokwu BO; Ernsberger P
J Auton Nerv Syst; 1998 Jul; 71(2-3):167-74. PubMed ID: 9760053
[TBL] [Abstract][Full Text] [Related]
19. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
Mukaddam-Daher S; Menaouar A; Gutkowska J
Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
[TBL] [Abstract][Full Text] [Related]
20. Sympathoexcitation of moxonidine in the caudal ventrolateral medulla is dependent on I1-imidazoline receptors in anesthetized rats.
Wang LG; Gao L; Wang W; Yuan WJ; Wang WZ
Neurosci Lett; 2007 Oct; 426(2):91-6. PubMed ID: 17889438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
